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Assemblyirus (MMTV) is the prototypical member of the Betaretrovirus genus, but the
processes of its morphogenesis are poorly characterized. In this report, we describe an unusual intracellular
processing of MMTV Gag polyprotein in human 293T cells transiently expressing MMTV from heterologous
promoter. The same speciﬁc cleavage products of the viral protease were seen for the wild type as well as for
nonmyristylated mutant of MMTV Gag polyprotein completely defective in the particle release. Inactivation
of the viral protease resulted in more stable Gag polyprotein and in accumulation of intracytoplasmic
particles for nonmyristylated Gag. The intracellular processing of nonmyristylated MMTV Gag indicates that
protease activation in betaretrovirus can occur independently of budding.
© 2008 Elsevier Inc. All rights reserved.IntroductionMouse mammary tumor virus (MMTV) is a member of the Betar-
etrovirus genus characterized by the ability to preassemble intracyto-
plasmic particles within the cell. The immature particles then relocate
to the plasma membrane, become enveloped, and are released. In
general, retrovirus particle assembly is driven by the Gag precursor,
the major structural polyprotein, which is sufﬁcient for forming virus-
like particles (Swanstrom and Wills, 1997). During or shortly after
particle release, the Gag polyprotein is cleaved by the viral protease
into multiple structural proteins. The N-terminal covalent modiﬁca-
tion of Gag by a myristic acid moiety is required for efﬁcient
membrane interaction and assembly of most retrovirus Gag poly-
proteins or transport and envelopment of preassembled betaretroviral
particles (Swanstrom and Wills, 1997). When myristylation is
prevented by deletion or substitution of the Gag N-terminal glycine
residue, accumulation of Gag polyproteins occurs and particle
production is abolished for most retroviruses. Blocking the N-terminal
myristylation in the betaretrovirus Mason–Pﬁzer monkey virus (M-
PMV) does not abolish assembly of intracytoplasmic particles, but
these accumulate within the cell, remain immature and are not
transported to the plasma membrane for release (Rhee and Hunter,
1987). Here, we demonstrate the unusual intracellular processing of
both wt and nonmyristylated MMTV Gag polyproteins by the viral
protease in transiently transfected human 293T cells. Elimination ofburg, Maryland 20877, USA.
l rights reserved.viral protease activity resulted in increased Gag stability and in
accumulation of intracytoplasmic particles for nonmyristylated poly-
protein. Speciﬁc products of the intracellular cleavage of Gag observed
in 293T cells were also detected at lower levels in mouse mammary
cells (Mm5MT) chronically infected with MMTV.
Results
Stability of MMTV Gag within the cell is affected by viral protease
activity
MMTV expression in infected mammary epithelial cells is
transcriptionally regulated by steroid hormones and therefore readily
detectable expression of viral proteins in tissue culture requires
glucocorticoid hormone stimulation of stably producing cells. Here we
tested transient production of MMTV in human embryonic kidney
293Tcells, which have previously been demonstrated to be permissive
for MMTV replication upon stable introduction of proviral DNA (Indik
et al., 2005). When we used the MMTV proviral clone pHYB-MTV
(Shackleford and Varmus, 1988) (Fig. 1) for transient transfection of
dexamethasone stimulated 293T cells, expression of the Gag poly-
protein precursor as well as production of virus associated proteins
was undetectable (Fig. 2A). To overcome this limitation, we con-
structed a chimeric proviral vector pSMt-HYB containing the 5′LTR
from M-PMV and the remaining proviral sequence from pHYB-MTV
(Fig. 1). This construct can produce assembled, but noninfectious
MMTV due to the non-homologous M-PMV sequences at the 5′ end of
the viral RNA, which would prevent ﬁrst strand transfer and thus
complete reverse transcription by virus-like particles.
Fig. 1. Schematic representation of proviral constructs tested for transient production of MMTV. Relative positions of the gag, pro, pol, env, rem and sag genes within the proviral
sequence are indicated. The origin of individual proviral sequences is speciﬁed and restriction sites used in this study are shown. (M-PMV —Mason–Pﬁzer monkey virus, LTR— long
terminal repeat, pbs — primer binding site, SD — splice donor site, SA — splice acceptor site).
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resulted in the expression of viral polyproteins in the producing cells
and alsodetectable levels of viral proteins released into themedium (Fig.
2A). Metabolic labeling yielded also some capsid (CA) related proteins
with molecular masses smaller than Gag as seen by immunoprecipita-
tionwith anti-CA polyclonal serum. Themost abundant of these protein
species was a protein of approximately 30 kDa (p30), which was also
seen in chased cells and at a very low but detectable level in viral
particles released from cells. This protein was previously reported to be
present in mature virions produced by chronically infected mouse
Mm5MT cells (Ott et al., 2003). Based on its apparent molecular weight
in SDSPAGE, theproteinwas speculated to be an incompletely processed
Gag polyprotein fragment containing domains p8-CA in that study. In
addition to this p30 cleavage intermediate, present in both pulse labeled
and chased cells,we also observedmature CA in chased cells. Although a
small amount of mature CA is often seen in producing cells for most
retroviruses, the amount of MMTV Gag cleavage products observed in
293T cells was unusually high.
To investigate if the processing of the Gag polyprotein in transfected
cells is mediated by the viral protease, or by cellular enzymes, we
completely removed the protease coding region from the MMTV
proviral construct (Fig. 1). With the deletion of approximately 2500 bp
majority of pol gene was also removed. Using the resulting construct
pSMt-HYBΔpro, the Gag structural polyprotein and the envelope
glycoproteins could be synthesized in transfected cells; however, the
production of Gag-Pro and Gag-Pro-Pol polyprotein precursors contain-
ing the viral enzymes is blocked. The transient transfection of 293Tcells
by pSMt-HYBΔpro resulted in the expression of stable MMTV Gag
polyprotein in cells as well as in the production of immature
extracellular virus like particles containingonly Gag (Fig. 2B). In contrast
to theparental pSMt-HYB construct,wedetected a signiﬁcant amount of
unprocessed Gag precursor and no 30 kDa CA-related protein ormature
CA in the chased cells transfected with this protease deﬁcient proviral
construct, suggesting a role forMMTVprotease inproteolytic processing
of cell-associated Gag. Additional minor protein bands smaller than Gag
that could be seen in cells regardless of viral protease activity are likely
products of either internal initiation of translation within gag or
degradation of Gag by cellular enzymes.
These results were further conﬁrmed by the behavior of a protease
active site mutant where the catalytically required aspartate in position
26 within the conserved triplet DTG has been changed to alanine. 293T
cells transiently transfected with proviral construct pSMt-HYB/D26A,
carrying the protease mutation, produced primarily the full lengthpolyprotein precursors Gag, Gag-Pro and Gag-Pro-Pol (Fig. 2B). Neither
p30 nor CA cleavage products were detected in these cells conﬁrming a
requirement forMMTVprotease activity inpremature processing of Gag
polyproteins.
Premature processing of MMTV Gag reduces intracellular assembly of
immature particles
To investigate the potential impact premature processing of Gag has
on assembly of immature particles, we mutated the N-terminal
myristylation site of MMTV Gag by changing the glycine residue to
alanine (pSMt-HYB/Myr−). The myristylation minus mutant produced
Gag degradation products including p30 and mature CA protein similar
to the pSMt-HYB construct. As expected, no extracellular virus particles
were released in the medium from metabolically labeled cells trans-
fected with pSMt-HYB/Myr− (Fig. 2C). However, deletion of the protease
coding region in pSMt-HYB/Myr−, yielding the construct pSMt-HYBΔ-
pro/Myr−, lead to a signiﬁcant increase in Gag accumulationwithin cells
andnodetectable products of proteolytic processing, suchas p30andCA,
were observed for this mutant (Fig. 2C). These data further conﬁrm that
the viral protease participates in premature processing of MMTV Gag
polyproteins in cells and suggest that the premature intracellular
activation of MMTV protease is independent of the budding process.
To directly examine assembly of MMTV immature particles we
performed transmission electron microscopy of 293T cells transfected
with wt and mutated viral constructs. The morphology of MMTV
produced by chronically infected mouse mammary cells has been
described previously by both negative-stain electron microscopy
(Nermut, 1973) and cryoelectron microscopy (Briggs et al., 2004). A
typical matured viral core is eccentrically located, irregularly sized and
shaped, and is often angular. It was reported not to be signiﬁcantlymore
electron-dense than the rest of the virion (Briggs et al., 2004). Consistent
with the low level of particle production that we observed for the pSMt-
HYB construct only small numbers of individual particles leaving the
transfected cells were observed. Intracytoplasmically preassembled
structures were not seen (Fig. 3). Particles produced by cells transfected
with pSMt-HYBΔpro exhibited the typical immature morphology of
empty spherical particles (Fig. 3). Consistentwith the results ofmetabolic
labeling, where the elimination of protease activity resulted in a high
level of extracellular Gag, we observed a higher number of particles
leaving producing cells. Intracytoplasmic immature capsids were also
sporadically observed for the Δpro construct. Cells transfected with
pSMt-HYB/Myr− contained no intracytoplasmic particles (not shown), in
Fig. 2. Pulse-chase analysis of MMTV Gag in transiently transfected 293T cells. Cells
were pulse-labeled with [35S]-methionine and [35S]-cysteine for 1 h and then chased
overnight. Released viral particles were collected from the medium, ﬁltered through a
0.45-μm-pore-size ﬁlter and pelleted through a 20% (w/v) sucrose cushion. Viral
proteins were immunoprecipitated with polyclonal rabbit anti-CA serum, separated by
12% SDS-PAGE and subjected to phosphorimager analysis. The positions of Gag, Gag-Pro,
and Gag-Pro-Pol precursors, Gag cleavage product p30, and proteolytically mature CA
protein are indicated. P— pulse labeled cells, C— chased cells, V— virions pelleted from
culture ﬂuids of chased cells. Panel A. Comparison of virus production in cells
transfected with proviral constructs pHYB-MTV and pSMt-HYB. Panel B. Comparison of
virus production in cells transfected with pSMt-HYB and its variants carrying the
deletion or mutation inactivating the viral protease, pSMt-HYBΔpro (Δpro) or pSMt-
HYB/D26A (Pr-D26A) respectively. Panel C. Synthesis and processing of MMTV Gag
lacking myristylation. Cells transfected with pSMt-HYB, pSMt-HYB/Myr− and pSMt-
HYBΔpro/Myr− proviral constructs expressed the wild type (SMt-HYB), myristylation
mutant (Myr−), or the myristylation mutant in the context of protease deﬁcient virus
(Δpro/Myr−) as indicated at the top of the gel lanes.
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such immature capsid-like structures were observed (Fig. 3). These
observations further support our previous results suggesting that loss of
viral protease activity increases MMTV Gag stability within 293T cells
and consequently the intracellular assembly of immature capsids.
Processing of Gag in chronically infected mouse mammary gland cells
The processes of assembly and budding may depend on both the
level of expression and the cell line used. Therefore we also examined
processing of Gag in the chronically infected mouse mammary glandcell line Mm5MT (Fig. 4). Pulse-chase analysis of MMTV expression
driven from the homologous LTR promoter sequence in dexametha-
sone stimulated cells revealed a similar pattern of individual CA-
related proteins in cells and also the presence of the p30 cleavage
product after 1 h of labeling. The amount of p30 relative to the amount
of unprocessed Gag was approximately 6 times lower in the infected
Mm5MT cells (Fig. 4) than in 293T cells transiently transfected with
the pSMt-HYB construct (see Fig. 2). Although the amount of the p30
cleavage intermediate is reduced in pulse labeled Mm5MT cells, its
early presence suggests that the intracellular cleavage of Gag occurs
also in the infected mouse mammary epithelial cells.
Discussion
There are numerous reports describing MMTV-like sequences
associatedwith human breast cancer (reviewed in Lawson et al., 2006)
and more recently a virus with a high degree of sequence homology
with MMTV, the human betaretrovirus (HBRV), has been identiﬁed as
the suspected etiologic agent of primary biliary cirrhosis (Xu et al.,
2003). These ﬁndings and the reported ability of MMTV to infect
human cells (Indik et al., 2005) provide a new impetus to investigate
the morphogenesis of this virus. Although the processes of assembly
and budding for the prototypical betaretrovirus M-PMV are well
characterized in many aspects, there is surprisingly little information
in this regard about MMTV as the other betaretroviral model. MMTV
follows the same assembly pathway as M-PMV but its Gag polyprotein
does not contain an apparent internal scaffold domain similar to the
M-PMV p12 region (Zábranský et al., 2005). Thus, there may be
different mechanisms for efﬁcient MMTV Gag multimerization
leading to intracytoplasmic retrovirus particle assembly.
Using transient transfection/expression analysis we demonstrated
MMTV particle production in permissive human 293T cells, but we
observed an unusual level of intracellular Gag cleavage by the viral
protease. The same cleavage products were seen for wild type as well
as for a nonmyristylated mutant of MMTV Gag that is defective in
particle release. Consistent with the idea that assembly and particle
production by MMTV may be regulated by intracellular activity of the
viral protease, inactivation of MMTV protease by deletion or mutation
enabled efﬁcient formation of immature capsids for wild type MMTV
Gag polyprotein and accumulation of intracytoplasmic particleswithin
293T cells for nonmyristylated Gag. Similar MMTV Gag processing
products were observed also in chronically infected murine cells,
which shows that premature processing of Gag polyproteins in cells is
not only related to transient expression driven fromaheterologous LTR
in human 293T cells but is a feature of MMTV itself.
The long-standing model of retroviral protease activation closely
links this event to particle envelopment and budding; however, the
precise mechanism by which the protease becomes activated is poorly
understood. A low level of Gag cleavage products can be seen in the
producing cells for most retroviruses, but these are commonly
attributed to particles arrested in budding or to particles that remain
associated with the exterior of the cell.
Elimination of efﬁcient membrane interaction usually excludes
retroviral Gag proteins from particle release and maturation. Early
studies of nonmyristylated Gag mutants of viruses such as human
immunodeﬁciency virus (HIV, lentivirus) (Bryant and Ratner, 1990) or
Moloneymurine leukemiavirus (MMLV, gammaretrovirus) (Schultz and
Rein, 1989) showed that while these Gag mutants fail to assemble they
nonetheless remain stable in transfected cells. It should be noted that
some proteolysis of nonmyristylated HIV-1 Gag was detected in COS-1
cells suggesting an inﬂuence of cell type on polyprotein stability
(Göttlinger et al., 1989). The importance of a membrane interaction for
protease activation is evident also in alpharetroviruses, such as Rous
sarcomavirus (RSV),where theGagpolyprotein is acetylated rather than
myristylated and its associationwith the cellularmembrane ismediated
solely through basic residues in itsM domain.Mutations in RSVMA that
Fig. 3. Analysis of MMTV particle production in 293T cells by thin-section electron microscopy. Representative ﬁelds from analysis of cells transfected with pSMt-HYB (WT), pSMt-
HYBΔpro (Δpro) and pSMt-HYBΔpro/Myr− (Δpro/Myr−) expressing the wild type, protease deﬁcient virus and myristylation mutant of Gag in the context of protease deﬁcient virus,
respectively. Solid arrows indicate extracellular MMTV particles. Open arrows indicate intracytoplasmically assembled structures. Scale bar, 500 nm.
36 A. Zábranský et al. / Virology 384 (2009) 33–37block budding also diminish processing and increase stability of
intracellular Gag (Callahan and Wills, 2000). However, in the case of
HIV-1,mutations that alter the frameshift and thus the ratio ofHIV-1Gag
and Pol proteins resulted in intracellular activation of protease and an
absence of virion production (reviewed in Adamson and Freed, 2007).
Premature intracellular processing of overexpressed HIV-1 Gag-Pol was
shown to be independent of myristylation (Karacostas et al., 1993;
Mergener et al., 1992).
Studies to analyze the function of myristylation for M-PMV Gag
found that lack of myristylation results in intracellular accumulation
of the polyprotein assembled into particles and no detectable level of
viral protease activity (Rhee and Hunter, 1987). Moreover, in a study
where the N-terminal matrix domainwas completely deleted fromM-
PMV Gag, the polyprotein also assembled efﬁciently into intracyto-
plasmic virus-like particles and large intracellular clusters of these
structures were seen by thin section EM analysis (Sakalian and Rapp,
2006). Thematrix-deletedM-PMVGagwas also shown to be relatively
stable in human HeLa cells since a signiﬁcant amount of nondegraded
metabolically labeled polyprotein was still present in the overnight
chased cells. Based upon these and other studies with M-PMV, it was
thought that protease activation in betaretroviruses, where immature
particles assemble inside cells, must be very tightly controlled. It has
been proposed that reversible oxidation of Cys residues in M-PMV
protease could regulate its activation (Parker and Hunter, 2001;
Zábranská et al., 2007); however, the details of this mechanism have
yet to be described. Previously the characteristics of MMTV protease
were known solely from in vitro examination of bacterially expressedFig. 4. Pulse-chase analysis of Gag synthesis and processing in mouse mammary gland
cells chronically infected with MMTV. Mm5MT cells stimulated with 0.1 μM
dexamethasone were pulse-labeled with [35S]-methionine and [35S]-cysteine for 1 h
and then chased overnight. Viral proteins were analyzed as described in the legend to
Fig. 2. (P, C, V—see the legend to Fig. 2).protein, where the enzyme was shown to be an active homodimer
exhibiting similarities (e.g. optimal pH and ionic strength) to other
retroviral proteases (Menendez-Arias et al., 1992). We have now
demonstrated that regulation of the MMTV protease in mammalian
cells, in contrast to the protease of the largely similar M-PMV, is
independent of virus budding and results in signiﬁcant intracellular
processing of the MMTV Gag precursor.
Materials and methods
DNA constructs
MMTV proviral clone pHYB-MTV, comprised of two halves from
different strains, endogenous Mtv-1 and exogenous C3H, (Shackleford
and Varmus, 1988) was kindly provided by Gregory Shackleford
(University of Southern California, Los Angeles, USA). The pSMt-HYB
vector for transient production of MMTV was constructed in M-PMV
expression plasmid pSARM4 (Song and Hunter, 2003), where M-PMV
proviral sequence downstream of 5′LTR segment (KasI–EcoRI) in
pSARM4 was cleaved off and replaced with corresponding MMTV
proviral sequence downstream of 5′LTR from pHYB-MTV. The plasmid
pSMt-HYBΔpro with the deletion of pro gene was created by the
excision of pro containing XbaI–HindIII fragment from pSMt-HYB
plasmid. The plasmid containing the rest of proviral sequence was
treated with T4 DNA polymerase to blunt the ends and religated.
D26A mutation inactivating the protease was constructed by site-
directed mutagenesis in pSMt-HYB plasmid. Brieﬂy, two complemen-
tary mutagenic primers carrying the mutation and silently introdu-
cing new restriction site for NruI were used for two PCR reactions,
each in the opposite direction. The resulting PCR product containing
mutation with the upstream portion of the proviral sequence was
cleaved by XbaI and NruI enzymes while the downstream PCR product
was treated with NruI and HindIII. They were both simultaneously
ligated into pSMt-HYB vector cleaved by XbaI and HindIII.
The glycine to alanine substitution at the N-terminus of Gag was
prepared by oligonucleotide-directed mutagenesis in plasmid pSMtv
containing only MMTV gag sequence. The mutation containing
fragment KasI–XbaI was introduced into plasmids pSMt-HYB and
pSMt-HYBΔpro to create pSMt-HYB/Myr− and pSMt-HYBΔpro/Myr−,
respectively. All described mutations were conﬁrmed by sequencing.
Sequences of all primers and detailed cloning procedures will be
provided to interested readers upon request.
Cell lines and transfections
Human kidney embryonic cells 293T (ATCC) and mouse mammary
cells Mm5MT (ATCC) were maintained in Dulbecco's modiﬁed Eagle's
37A. Zábranský et al. / Virology 384 (2009) 33–37medium (DMEM) supplemented with 10% fetal bovine serum, 20 mM
L-glutamine (Sigma Aldrich). 293T cells were transfected by FuGENE
HD (Roche Molecular Biochemicals) reagent according to the
manufacturer's instructions. Virus production in the infected cells
Mm5MT or 293T cells transfected with pHYB-MTV was stimulated by
0.1 μM dexamethasone (Sigma-Aldrich).
Metabolic labeling and immunoprecipitation
Cells were grown on 60 mm culture dishes, 24 h posttransfection
were 3 times washed with PBS buffer and then pulse-labeled for
60 min at 37°C in 1 mL of DMEM without methionine and cysteine
supplemented with 100 μCi of [35S]methionine-[35S]cysteine protein-
labeling mix (MP Biochemicals). The label was chased overnight (15 h)
by replacing the labeling medium with complete DMEM. For analysis
of intracellular viral proteins, the cells were lysed in buffer containing
0.15 M NaCl, 50 mM Tris–HCl (pH 7.5), 1% Triton X-100, and 1%
deoxycholate (Lysis Buffer). Cellular debris and nuclei were removed
by centrifugation for 1 min at 14,000 rcf. The lysate was then adjusted
to 0.1% SDS and the cell-associated viral proteins were immunopre-
cipitated by rabbit polyclonal anti-CA antiserum for 1 h and after
addition of protein A immobilized on Sepharose beads (Invitrogen)
the suspension was incubated for 2 h. For analysis of released virus
particles, tissue culture medium was ﬁrst ﬁltered through a 0.45 μm
ﬁlter. Particles were then collected by centrifugation through a 20% w/
v sucrose cushion at 35,000 rpm for 1 h in a SW 41 Ti rotor (Beckman-
Coulter). Pelleted virions were dissolved in Lysis Buffer containing
additional 0.1% SDS and the virus-associated proteins were immuno-
precipitated as described for cell lysates. Radiolabeled proteins were
separated on SDS-12% PAGE gels and detected by autoradiography.
Electron microscopy
Examined cells were washed in PBS and ﬁxed by 3% glutaraldehyde
in 0.1 M cacodylate buffer, pH 7.4. The cells were postﬁxed with 1%
osmium tetroxide, dehydrated in graded ethanol solutions and
embedded in epoxy resin AGAR 100. Ultrathin sections (70 nm) were
stained with uranyl acetate and lead citrate. The samples were analyzed
with a JEOL JEM-1200EX electron microscope operated at 60 kV.
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